financetom
Business
financetom
/
Business
/
Masimo smartwatches infringe Apple design patents, US jury says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masimo smartwatches infringe Apple design patents, US jury says
Nov 3, 2024 12:04 PM

Oct 25 (Reuters) - Apple ( AAPL ) convinced a federal

jury on Friday that health monitoring tech company Masimo's ( MASI )

smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple ( AAPL ) that Masimo's ( MASI ) W1

and Freedom watches and chargers willfully violated Apple's ( AAPL )

patent rights in smartwatch designs, awarding the tech giant

$250 in damages. Apple's ( AAPL ) attorneys told the court the "ultimate

purpose" of its lawsuit was to win an injunction against sales

of Masimo's ( MASI ) smartwatches after an infringement ruling.

The jury also determined that Masimo's ( MASI ) watches did not

infringe Apple ( AAPL ) patents covering smartwatch inventions that the

tech giant had accused Masimo ( MASI ) of copying.

Masimo ( MASI ) said in a statement that the company appreciated the

jury's verdict "in favor of Masimo ( MASI ) and against Apple ( AAPL ) on nearly

all issues," and that the decision only applied to a

"discontinued module and charger."

"Apple ( AAPL ) primarily sought an injunction against Masimo's ( MASI )

current products, and the jury's verdict is a victory for Masimo ( MASI )

on that issue," Masimo ( MASI ) said.

Apple ( AAPL ) said in a statement that it was "glad the jury's

decision today will protect the innovations we advance on behalf

of our customers."

Irvine, California-based Masimo ( MASI ) accused Apple ( AAPL ) of hiring

away its employees and stealing its pulse oximetry technology

after discussing a potential collaboration. Masimo ( MASI ) convinced the

U.S. International Trade Commission last year to block imports

of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches after the

commission found that their technology for reading blood oxygen

levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) has appealed the decision and resumed selling the

watches after removing the technology. The tech giant

countersued Masimo ( MASI ) for patent infringement in 2022, alleging

that Masimo ( MASI ) copied Apple Watch features to use in its

smartwatches.

Apple ( AAPL ) also accused Masimo ( MASI ) of using lawsuits at the ITC

and in California to "make way for Masimo's ( MASI ) own watch." Masimo ( MASI )

said Apple's ( AAPL ) patent lawsuit was "retaliatory" and "an attempt to

avoid the court in which the parties have been litigating their

dispute."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Reddit deploys fix for outage affecting thousands in US
Reddit deploys fix for outage affecting thousands in US
Nov 20, 2024
(Reuters) - Reddit ( RDDT ) said on Wednesday it has rolled out a fix for a software bug that prevented tens of thousands of people from accessing the social media platform in the U.S. The outage began around 3 pm ET, according to Downdetector, which tracks outages by collating status reports from several sources including users reports. At the...
AppLovin Prices $3.55 Billion Debt Offering
AppLovin Prices $3.55 Billion Debt Offering
Nov 20, 2024
05:54 PM EST, 11/20/2024 (MT Newswires) -- AppLovin ( APP ) said late Wednesday it priced a $3.55 billion public offering of its senior notes. The offering comprises $1 billion of 5.125% notes due 2029, $1 billion of 5.375% notes due 2031, $1 billion of 5.5% notes due 2034, and $550 million of 5.95% notes due 2054. The company said...
Karyopharm Therapeutics Appoints Kristin Abate as Chief Accounting Officer
Karyopharm Therapeutics Appoints Kristin Abate as Chief Accounting Officer
Nov 20, 2024
05:54 PM EST, 11/20/2024 (MT Newswires) -- Karyopharm Therapeutics ( KPTI ) said Wednesday it appointed Kristin Abate as chief accounting officer, starting Wednesday. Abate, who previously was working as interim principal accounting officer, will continue to serve the position on permanent basis. Abate will continue to serve as interim principal financial officer. ...
Loandepot Insider Sold Shares Worth $863,772, According to a Recent SEC Filing
Loandepot Insider Sold Shares Worth $863,772, According to a Recent SEC Filing
Nov 20, 2024
04:57 PM EST, 11/20/2024 (MT Newswires) -- Anthony Li Hsieh, 10% Owner, Director, on November 18, 2024, sold 364,529 shares in Loandepot ( LDI ) for $863,772. Following the Form 4 filing with the SEC, Hsieh has control over a total of 6,919,381 shares of the company, with 73,781 shares held directly and 6,845,600 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1831631/000183163124000293/xslF345X05/wk-form4_1732139521.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved